Effects of Botulinum Toxin Injection Combined with RESWT in Lower Extremity Spasticity in Children with Cerebral Palsy

The Effects of Botulinum Toxin Type a Injection Combined with RESWT in Lower Extremity Spasticity in Children with Cerebral Palsy

This study aimed to check and compare the effects of botulinum toxin injection combined with shock wave therapy versus botulinum toxin injection only for lower extremity spasticity in children with cerebral palsy

20 pediatric patients diagnosed with cerebral palsy who received botulinum toxin type A injection for lower extremity spasticity were divided into two groups. The first group will receive only conventional treatment after the injection, while the second group will receive extracorporeal shockwave therapy for injected muscles. The shock wave therapy is planned as 3 sessions per week, starting one week after the injection. Patients will be compared in terms of MAS scores, MTS scores, passive joint range of motion, modified timed up and go test, pain scores, (faces pain scale-revised) and Goal Attainment Scaling scores. Patients will be evaluated 1 week, 1 month and 3 months after the injection with pre-injection data.

Inclusion Criteria:

• Diagnosed with cerebral palsy.
• Spasticity in at least one of the lower extremity muscle groups.
• No contraindications to shockwave therapy.
• Applied Botulinum Toxin Type A injection for at least one spastic muscle of lower extremity.
• Agreed to participate to study (patient/primary caregiver)

Exclusion Criteria:

• Surgery history within the last year of the muscle to be injected and treated
• Having uncontrolled epilepsy.
• Having infection
• Coagulopathy